Board Meetings for GLENMARK

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
GLENMARKGlenmark Pharmaceuticals Limited14 Nov 2024Financial ResultsTo consider and approve the financial results for the period ended September 30, 2024
GLENMARKGlenmark Pharmaceuticals Limited14 Aug 2024GLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .Board Meeting Intimation
GLENMARKGlenmark Pharmaceuticals Limited14 Aug 2024Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2024
GLENMARKGlenmark Pharmaceuticals Limited24 May 2024Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2024 and dividend
GLENMARKGlenmark Pharmaceuticals Limited24 May 2024GLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 24-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend.Board Meeting Intimation
GLENMARKGlenmark Pharmaceuticals Limited14 Feb 2024Financial ResultsTo consider and approve the financial results for the period ended December 31, 2023
GLENMARKGlenmark Pharmaceuticals Limited14 Feb 2024GLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .Board Meeting Intimation
GLENMARKGlenmark Pharmaceuticals Limited10 Nov 2023GLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .Board Meeting Intimation
GLENMARKGlenmark Pharmaceuticals Limited10 Nov 2023Financial ResultsTo consider and approve the financial results for the period ended September 30, 2023
GLENMARKGlenmark Pharmaceuticals Limited11 Aug 2023Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2023
GLENMARKGlenmark Pharmaceuticals Limited19 May 2023GLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 19-May-2023 to consider financial statements for the period ended March 2023, Financial results/Dividend.Board Meeting Intimation
GLENMARKGlenmark Pharmaceuticals Limited19 May 2023Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2023 and dividend
GLENMARKGlenmark Pharmaceuticals Limited10 Feb 2023Financial ResultsBoard Meeting intimation for Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2022.
GLENMARKGlenmark Pharmaceuticals Limited11 Nov 2022Financial resultsBoard Meeting Intimation For Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2022.
GLENMARKGlenmark Pharmaceuticals Limited10 Aug 2022Financial resultsGlenmark Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 10-Aug-2022 to consider financial statements for the period ended June 2022
Showing page 2 of 8 (110 total items)